InMed Pharmaceuticals (INM) EBITDA Margin Growth (1y) (2022 - 2025)
Powered by 
Analysis
InMed Pharmaceuticals (INM) EBITDA Margin Growth (1y) (2022 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.18 Bn | 142.67 Bn | 1.63 Bn | 66.00 |
| 2 | Ati | 28.28 Bn | 27.50 Bn | 309.80 Mn | 333.00 |
| 3 | Qnity Electronics | 26.28 Bn | 25.32 Bn | 666.00 Mn | 28.00 |
| 4 | International Flavors & Fragrances | 21.50 Bn | 20.93 Bn | 853.00 Mn | 69.00 |
| 5 | DuPont de Nemours | 17.40 Bn | 15.66 Bn | 639.00 Mn | 139.00 |
| 6 | Avery Dennison | 12.97 Bn | 12.74 Bn | 729.40 Mn | 67.00 |
| 7 | Solstice Advanced Materials | 10.03 Bn | 9.28 Bn | 370.00 Mn | -331.00 |
| 8 | Element Solutions | 8.73 Bn | 8.54 Bn | 334.00 Mn | -346.00 |
| 9 | Eastman Chemical | 7.82 Bn | 7.13 Bn | 560.00 Mn | 53.00 |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -5,470.00 |
| Sep 30, 2025 | -2,643.00 |
| Jun 30, 2025 | -3,011.00 |
| Mar 31, 2025 | 580.00 |
| Dec 31, 2024 | -7,017.00 |
| Sep 30, 2024 | 15,872.00 |
| Jun 30, 2024 | -13,769.00 |
| Mar 31, 2024 | 5,104.00 |
| Dec 31, 2023 | 33,805.00 |
| Sep 30, 2023 | 81,991.00 |
| Jun 30, 2023 | 124,618.00 |
| Mar 31, 2023 | 38,283.00 |
| Dec 31, 2022 | 115,710.00 |